Read by QxMD icon Read

Cardiac Catheterization laboratory staffing

A M Powell, J M Halon, J Nelson
INTRODUCTION: Emergent care of the acute heart attack patient continues to be at the forefront of quality and cost reduction strategies throughout the healthcare industry. Although the average cardiac door-to-balloon (D2B) times have decreased substantially over the past few years, there are still vast disparities found in D2B times in populations that reside in rural areas. Such disparities are mostly related to prolonged travel time and subsequent delays in cardiac catherization lab team activation...
2014: Rural and Remote Health
Karine Chevreul, Matthias Brunn, Benjamin Cadier, Georges Haour, Hélène Eltchaninoff, Alain Prat, Alain Leguerrier, Didier Blanchard, Gérard Fournial, Bernard Iung, Patrick Donzeau-Gouge, Christophe Tribouilloy, Jean-Louis Debrux, Alain Pavie, Martine Gilard, Pascal Gueret
BACKGROUND: Currently, several anatomical approaches and intervention sites can be used to perform transcatheter aortic valve implantations (TAVIs), often with no clinical indications for choosing one or another. While these choices can have an impact on resource consumption, no costing study is available in the European context to provide information on resource use and assist decision-making. AIMS: To provide comparative data on the cost of the TAVI procedure, depending on anatomical approach and intervention site used, from a hospital perspective, and to analyze factors associated with cost of hospital stay...
April 2013: Archives of Cardiovascular Diseases
James W Jones, Laurence B McCullough, Bruce W Richman
A 300-bed general hospital in a mid-sized city has a busy cardiac catheterization laboratory, with 12 invasive cardiologists and more than 4000 annual procedures. An invasive radiology suite, the only one in town, is staffed by a single invasive radiologist and two vascular surgeons. They perform about 150 diagnostic angiograms and endovascular procedures each year, about half of which are generated by consultation requests from the cardiologists. The invasive radiology team has worked together for the last 5 years, since an endovascular fellowship-trained vascular surgeon joined the staff...
September 2005: Journal of Vascular Surgery
R K Sareen, S M Garg, R K Garg, M S Kumar, S K Matwankar
An attempt has been made to identify the main factors involved in the costing of a Cardiac Catheterisation Procedure (CCP). The technique of historical costing was used. The cost of a CCP worked out to Rs. 4265.21. The direct costs contributed 62%, the indirect costs 2.6% and expenses contributed 35% to the total cost. All these factors were found to be sensitive to the volume and duration of CCP, hence administrators must assist the staff of cardiac catheterisation laboratory (CCL) in controlling these two factors for the cost-effectiveness and efficient utilisation of the CCL...
July 1997: Journal
J A Urbanowicz
Patient care using patient volume rather than acuity has been a long-standing problem in a cardiac catheterization laboratory in a central New Jersey Medical Center. The current pattern of staffing results in some of the nursing staff becoming unproductive from a patient care perspective. This recently has become a concern of the Vice President of Nursing who has the unpopular task of consolidating nursing positions. There is a very effective acuity measurement system, the Medicus Acuity System, in place for the various inpatient areas...
May 1999: Computers in Nursing
H D Papaconstantinou, A J Marshall, C J Burrell
OBJECTIVE: To assess the feasibility, safety, and clinical impact of diagnostic cardiac catheterisation in a multipurpose laboratory in a district general hospital without cardiac surgery. METHODS: A prospective audit of the first 2000 consecutive cases between September 1992 and March 1997. Unstable patients were referred to a surgical centre for investigation, in line with subsequently published British Cardiac Society (BCS) guidelines, but all other patients requiring cardiac catheterisation were investigated locally and are included in this report...
May 1999: Heart: Official Journal of the British Cardiac Society
T A Lieu, R J Gurley, R J Lundstrom, G T Ray, B H Fireman, M C Weinstein, W W Parmley
OBJECTIVES: This study sought to evaluate the cost-effectiveness of primary angioplasty for acute myocardial infarction under varying assumptions about effectiveness, existing facilities and staffing and volume of services. BACKGROUND: Primary angioplasty for acute myocardial infarction has reduced mortality in some studies, but its actual effectiveness may vary, and most U.S. hospitals do not have cardiac catheterization laboratories. Projections of cost-effectiveness in various settings are needed for decisions about adoption...
December 1997: Journal of the American College of Cardiology
S Silber
Quality assurance is a touchy subject: difficult to implement, time-demanding and expensive. The goal of quality assurance is to assist both the patients and the physicians. In addition to legal requirements, quality assurance is necessary for medical as well as economical reasons. It makes sense that the license to practice medicine does not automatically entail the right to perform all medical procedures; the development of new methods and the insights won from important scientific studies necessitates constant training...
October 1996: Herz
D A Murphy, J M Craver, E L Jones, A R Gruentzig, S B King, C R Hatcher
From September, 1980, through August, 1981, 353 patients underwent attempted percutaneous transluminal coronary angioplasty (PTCA). Twenty-seven patients (7.6%) subsequently underwent elective myocardial revascularization without death or complicating PTCA. Surgical support in the first 2 months involved a fully-staffed operating room standing idle. During the last 10 months, patients requiring emergency revascularization were accommodated in the first operating room available. All 17 patients undergoing emergency revascularization had severe chest pain and 12 patients had ST-segment elevation on the electrocardiogram...
September 1982: Journal of Thoracic and Cardiovascular Surgery
B D Carew, S A Ahn, H D Boichot, B J Dierenfeldt, N A Dolan, T R Edens, D H Weiner, J L Probstfield
SOLVD was a double-masked, placebo-controlled trial whose initial sample size goal was to randomize 6100 participants into two concurrent trials: treatment and prevention. The objective was to determine if participants with severe left ventricular dysfunction (left ventricular ejection fraction < or = 35%, with congestive heart failure (2569) and participants without overt heart failure (4228) had improved survival with angiotensin-converting enzyme inhibitors. Participants were identified from cardiac catheterization, echocardiography and radionuclide laboratories, and inpatient units...
October 1992: Controlled Clinical Trials
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"